Oxycodone G.L. (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxycodone G.L., is an opioid analgesic presented as a tablet for oral use. It is used to manage moderate to severe pain in adult patients when other analgesics are insufficient.

GNH USA supplies Oxycodone G.L. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone Hydrochloride is an opioid that acts on the central nervous system to relieve pain in several clinical contexts.

- Acute postoperative pain: provides strong analgesia after surgical procedures. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Severe chronic non‑cancer pain: reduces pain intensity when other treatments have failed. - Palliative care: improves comfort for patients with life‑limiting illnesses.

Adverse reactions to oxycodone may vary in frequency and severity.

Common Side Effects: - Nausea and vomiting: mild to moderate gastrointestinal upset. - Constipation: reduced bowel motility leading to hard stools. - Drowsiness or sedation: increased sleepiness or reduced alertness. - Dizziness: light‑headed sensation, especially when standing. - Dry mouth: reduced salivation causing oral discomfort. - Itching or rash: mild skin irritation or pruritus.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure leading to fainting. - Seizures: convulsive episodes in susceptible individuals. - Allergic anaphylaxis: rapid onset of swelling, hives, and airway compromise. - Dependence or addiction: potential for misuse and physical dependence with prolonged use. - Adrenal insufficiency: rare hormonal imbalance affecting stress response.

When prescribing oxycodone, clinicians should consider several safety measures.

- Assess pain severity and prior opioid use: determine if opioid therapy is appropriate. - Evaluate respiratory function: patients with compromised breathing are at higher risk. - Review concurrent CNS depressants: avoid additive sedation or respiratory effects. - Monitor for signs of dependence: watch for cravings, tolerance, or withdrawal. - Adjust dose in renal or hepatic impairment: reduced clearance may require lower dosing. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxycodone may interact with a range of medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Benzodiazepines: combined use can cause profound respiratory depression. - CNS depressants: alcohol, barbiturates, or other sedatives increase sedation risk. - MAO inhibitors: may precipitate hypertensive crisis or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): increase oxycodone plasma levels. - CYP2D6 inhibitors (e.g., fluoxetine): may reduce conversion to active metabolites. - Anticholinergic agents: can worsen constipation and urinary retention.